Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229–63.
van der Wal BC, Butzelaar RM, van der Meij S, et al. Axillary lymph node ratio and total number of removed lymph nodes: predictors of survival in stage I and II breast cancer. Eur J Surg Oncol. 2002;28(5):481–9.
Heidinger M, Weber WP. Axillary surgery for breast cancer in 2024. Cancers (Basel). 2024;16(9):1623.
Giuliano AE, Ballman KV, McCall L, et al. Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (alliance) randomized clinical trial. JAMA. 2017;318(10):918–26.
Article PubMed PubMed Central Google Scholar
Chen SL, Hoehne FM, Giuliano AE. The prognostic significance of micrometastases in breast cancer: a SEER population-based analysis. Ann Surg Oncol. 2007;14(12):3378–84.
Giuliano AE, Dale PS, Turner RR, et al. Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg. 1995;222(3):394–9.
Article PubMed PubMed Central CAS Google Scholar
van der Heiden-van der Loo M, Bezemer PD, Hennipman A, et al. Introduction of sentinel node biopsy and stage migration of breast cancer. Eur J Surg Oncol. 2006;32(7):710–4.
Andersson Y, Frisell J, Sylvan M, et al. Breast cancer survival in relation to the metastatic tumor burden in axillary lymph nodes. J Clin Oncol. 2010;28(17):2868–73.
Dosani M, Truong PT. Controversies in locoregional management of breast cancer with low volume pN0(i+) and pN1mi nodal disease. Expert Rev Anticancer Ther. 2019;19(9):803–10.
Article PubMed CAS Google Scholar
Jang BS, Shin KH. Postmastectomy radiation therapy in patients with minimally involved lymph nodes: a review of the current data and future directions. J Breast Cancer. 2022;25(1):1–12.
Article PubMed PubMed Central Google Scholar
Recht A, Comen EA, Fine RE, et al. Postmastectomy radiotherapy: an American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology focused guideline update. J Clin Oncol. 2016;34(36):4431–42.
Gradishar WJ, Moran MS, Abraham J, et al. Breast cancer, version 3.2024, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2024;22(5):331–57.
Kunkler IH. Does postmastectomy radiotherapy in 'intermediate-risk' breast cancer impact overall survival? 10 year results of the BIG 2-04 MRC SUPREMO randomised trial: on behalf of the SUPREMO trial investigators. SABCS meeting. 2024 (abstract number: SESS-3537)
Corti C, Batra-Sharma H, Kelsten M, et al. Systemic therapy in breast cancer. Am Soc Clin Oncol Educ Book. 2024;44(3): e432442.
Surveillance, Epidemiology, and End Results (SEER) Program (http://www.seer.cancer.gov) SEER*Stat Database: Incidence—SEER Research Data, 17 Registries, Nov 2022 Sub (2000–2020)—Linked To County Attributes—Time Dependent (1990–2021) Income/Rurality, 1969–2021 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, released April 2023, based on the November 2022 submission
Jung J, Kim BH, Kim J, et al. Validating the ACOSOG Z0011 trial result: a population-based study using the SEER database. Cancers (Basel). 202;12(4):950.
Zheng Q, Luo H, Xia W, et al. Long-term survival after sentinel lymph node biopsy or axillary lymph node dissection in pN0 breast cancer patients: a population-based study. Breast Cancer Res Treat. 2022;196(3):613–22.
Gou Z, Lu X, He M, et al. Trends in axillary surgery and clinical outcomes among breast cancer patients with sentinel node metastasis. Breast. 2022;63:9–15.
Article PubMed PubMed Central Google Scholar
Andersson Y, Bergkvist L, Frisell J, et al. Long-term breast cancer survival in relation to the metastatic tumor burden in axillary lymph nodes. Breast Cancer Res Treat. 2018;171(2):359–69.
Lupe K, Truong PT, Alexander C, et al. Ten-year locoregional recurrence risks in women with nodal micrometastatic breast cancer staged with axillary dissection. Int J Radiat Oncol Biol Phys. 2011;81(5):e681-688.
Lim SZ, Kusumawidjaja G, Mohd Ishak HM, et al. Outcomes of stage I and II breast cancer with nodal micrometastases treated with mastectomy without axillary therapy. Breast Cancer Res Treat. 2021;189(3):837–43.
Article PubMed CAS Google Scholar
Dosani M, Hamilton SN, Gondara L, et al. pN0(i+) and pN1mi breast cancer: treatment and outcomes in comparison with pN0 and pN1a in the modern era. Int J Radiat Oncol Biol Phys. 2022;113(4):805–15.
Wu SP, Tam M, Shaikh F, et al. Post-mastectomy radiation therapy in breast cancer patients with nodal micrometastases. Ann Surg Oncol. 2018;25(9):2620–31.
Jafer F, Malki S, Akram M, et al. Postmastectomy radiation therapy in breast cancer patients with micrometastatic disease in sentinel node dissection: a cohort study and meta-analysis. Clin Transl Radiat Oncol. 2024;46: 100770.
PubMed PubMed Central Google Scholar
Li B, Liu J, Wu G, et al. Evaluation of adjuvant therapy for T1–2N1miM0 breast cancer without further axillary lymph node dissection. Front Surg. 2023;9: 905437.
Article PubMed PubMed Central Google Scholar
Merfeld EC, Burr AR, Brickson C, et al. De-escalating locoregional therapy for axillary micrometastases in breast cancer: how much is too much? Clin Breast Cancer. 2022;22(4):336–42.
Patel M, Li C, Aronson JH, et al. The effect of post mastectomy radiation therapy on survival in breast cancer patients with N1mic disease. Breast. 2020;51:50–6.
Article PubMed PubMed Central Google Scholar
Balachandran VP, Gonen M, Smith JJ, et al. Nomograms in oncology: more than meets the eye. Lancet Oncol. 2015;16(4):e173-180.
Comments (0)